(3Z,6E)-5-(4-Chlorobenzenesulfonyl)-9-(2,4-dichlorophenyl)-2,8-dioxa-3,7-diazanona-3,6-diene

Catalog No. :
ACOTUQ892
CAS No. :
338395-35-0
Molecular Formula :
C17H15Cl3N2O4S
Molecular Weight :
449.74

IUPAC Name:(1E,3Z)-2-((4-chlorophenyl)sulfonyl)malonaldehyde O3-(2,4-dichlorobenzyl) O1-methyl dioxime

(3Z,6E)-5-(4-Chlorobenzenesulfonyl)-9-(2,4-dichlorophenyl)-2,8-dioxa-3,7-diazanona-3,6-diene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3Z,6E)-5-(4-Chlorobenzenesulfonyl)-9-(2,4-dichlorophenyl)-2,8-dioxa-3,7-diazanona-3,6-diene
IUPAC Name(1E,3Z)-2-((4-chlorophenyl)sulfonyl)malonaldehyde O3-(2,4-dichlorobenzyl) O1-methyl dioxime
MDL No.MFCD00201963
Molecular FormulaC17H15Cl3N2O4S
Molecular Weight449.74
SMILESCO/N=C\C(S(=O)(C1=CC=C(Cl)C=C1)=O)/C=N/OCC2=CC=C(Cl)C=C2Cl
InChI KeyUPJMUANOWZKVRH-CHQRTDLRSA-N
Synonym2-[(4-CHLOROPHENYL)SULFONYL]MALONALDEHYDE 1-[O-(2,4-DICHLOROBENZYL)OXIME] 3-(O-METHYLOXIME);(3Z,6E)-5-(4-chlorobenzenesulfonyl)-9-(2,4-dichlorophenyl)-2,8-dioxa-3,7-diazanona-3,6-diene;Propanedial, [(4-chlorophenyl)sulfonyl]-, O-[(2,4-dichlorophenyl)methyl]oxime O-methyloxime (9CI)
CAS No.338395-35-0

Synthetic Route by SureRoute

1. ACOTUQ892 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOTUQ892 route product structure diagram
    ACOTUQ892338395-35-0
Inquiry

2. ACOTUQ892 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCTFQ746 route compound structure diagram
    ACCTFQ74651572-93-1 In Stock
  4. Then
  5. ACOTUQ892 route product structure diagram
    ACOTUQ892338395-35-0
Inquiry

Comments (0)